QuikReader

QuikReader

  • Latest
  • Top stories
  • Business
  • Tech
  • World
  • Politics
  • Sports
  • Lifestyle
  • Health
  • Science
  • Entertainment
  • More
    • Sources
Sign in

Latest in Bluebird

Sort by
1 items

  • Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker

    Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
    CNBC - 1d
  • 1
  Follow topic
© 2025 QuikReader - About - Terms - Privacy